Literature DB >> 27990365

Comparison of the anti-inflammatory effects of fluorometholone 0.1% combined with levofloxacin 0.5% and tobramycin/dexamethasone eye drops after cataract surgery.

Pei-Qing Chen1, Xue-Mei Han2, Ya-Nan Zhu1, Jia Xu1.   

Abstract

AIM: To compare the combination of fluorometholone 0.1% and levofloxacin 0.5% to tobramycin/dexamethasone eye drops in controlling inflammation and preventing infection after phacoemulsification with an intraocular lens implantation.
METHODS: Sixty eyes from 60 patients undergoing cataract phacoemulsification were randomized into two groups; half of the patients were treated with fluorometholone (6 times/d) combined with levofloxacin (4 times/d), while the other half were treated with tobramycin/dexamethasone (4 times/d) eye drops for one week. Preoperative and postoperative intraocular pressure, aqueous flare, corneal thickness, and signs and symptoms were recorded before the operation and 1wk following treatments.
RESULTS: There were no statistically significant differences between the two groups in corneal thickness (P≥0.629), aqueous flare (P≥0.398), and signs and symptoms scores (P≥0.350) at each time point. Ocular hypertension was only observed in two eyes in the tobramycin/dexamethasone group.
CONCLUSION: Fluorometholone combined with levofloxacin treatment shows comparable efficacy but without the tendency to increase intraocular pressure; thus, it might be a better regimen for postoperative use.

Entities:  

Keywords:  fluorometholone; inflammation; levofloxacin; phacoemulsification; tobramycin/dexamethasone

Year:  2016        PMID: 27990365      PMCID: PMC5145090          DOI: 10.18240/ijo.2016.11.13

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  25 in total

1.  A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.

Authors:  Yi Qin; Shi Lam; Gary Hin Fai Yam; Kwong Wai Choy; David Tai Li Liu; Thomas Yee Hang Chiu; Wai Ying Li; Dennis Shun Chiu Lam; Chi Pui Pang; Dorothy Shu Ping Fan
Journal:  Acta Ophthalmol       Date:  2010-11-02       Impact factor: 3.761

2.  Prevention and control of perioperative incision infection in patients undergoing day cataract surgery.

Authors:  Chunyan Yang; Aihuan Chen; Yinghuan Wang; Xiaoqun Fang; Ronghua Ye; Jingyi Lin
Journal:  Eye Sci       Date:  2014-09

3.  Plasma cortisol and the intraocular pressure response to topical corticosteroids.

Authors:  B Becker; C K Ramsey
Journal:  Am J Ophthalmol       Date:  1970-06       Impact factor: 5.258

4.  Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation.

Authors:  K Matti Saari; Laura Nelimarkka; Virpi Ahola; Thorsteinn Loftsson; Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-11       Impact factor: 3.117

5.  Penetration of synthetic corticosteroids into human aqueous humour.

Authors:  C N McGhee; D G Watson; J M Midgley; M J Noble; G N Dutton; A I Fern
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

6.  Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial.

Authors:  Irini P Chatziralli; Leonidas Papazisis; Theodoros N Sergentanis
Journal:  Ophthalmologica       Date:  2010-09-24       Impact factor: 3.250

7.  Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%.

Authors:  A O Akingbehin
Journal:  Br J Ophthalmol       Date:  1983-10       Impact factor: 4.638

8.  The effects of dexamethasone on the Na,K-ATPase activity and pump function of corneal endothelial cells.

Authors:  Shin Hatou; Masakazu Yamada; Hiroshi Mochizuki; Atsushi Shiraishi; Takeshi Joko; Teruo Nishida
Journal:  Curr Eye Res       Date:  2009-05       Impact factor: 2.424

9.  The Cataract National Dataset electronic multi-centre audit of 55,567 operations: updating benchmark standards of care in the United Kingdom and internationally.

Authors:  P Jaycock; R L Johnston; H Taylor; M Adams; D M Tole; P Galloway; C Canning; J M Sparrow
Journal:  Eye (Lond)       Date:  2007-11-23       Impact factor: 3.775

10.  Gene expression profiles of human trabecular meshwork cells induced by triamcinolone and dexamethasone.

Authors:  Bao Jian Fan; Dan Yi Wang; Clement Chee Yung Tham; Dennis Shun Chiu Lam; Chi Pui Pang
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

View more
  5 in total

1.  Fixed-Combination Eye Drops Based on Fluorometholone Nanoparticles and Bromfenac/Levofloxacin Solution Improve Drug Corneal Penetration.

Authors:  Hiroko Otake; Ryoka Goto; Fumihiko Ogata; Takumi Isaka; Naohito Kawasaki; Shinichiro Kobayakawa; Toru Matsunaga; Noriaki Nagai
Journal:  Int J Nanomedicine       Date:  2021-08-10

2.  Thermoresponsive GenisteinNLC-dexamethasone-moxifloxacin multi drug delivery system in lens capsule bag to prevent complications after cataract surgery.

Authors:  Tingyu Yan; Zhongxu Ma; Jingjing Liu; Na Yin; Shizhen Lei; Xinxin Zhang; Xuedong Li; Yu Zhang; Jun Kong
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

3.  Cyclodextrin-containing hydrogels as an intraocular lens for sustained drug release.

Authors:  Xiao Li; Yang Zhao; Kaijie Wang; Lei Wang; Xiaohui Yang; Siquan Zhu
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

4.  Intracameral Triamcinolone Acetonide Versus Topical Dexamethasone: A Comparison of Anti-inflammatory Effects After Phacoemulsification.

Authors:  Kamran Haider Shaheen; Muhammad Saad Ullah; Syed Ahmer Hussain; Aamir Furqan
Journal:  Cureus       Date:  2020-04-08

5.  Corneal Thickness and Anterior Chamber Flare After Cataract Surgery: A Randomized Controlled Trial Comparing Five Regimens for Anti-Inflammatory Prophylaxis.

Authors:  Niklas Cyril Hansen; Jesper Høiberg Erichsen; Lars Morten Holm; Line Kessel
Journal:  Clin Ophthalmol       Date:  2021-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.